107 related articles for article (PubMed ID: 376458)
1. Disposition and antiarrhythmic effect of lorcainide.
Klotz U; Müller-Seydlitz P; Heimburg P
Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):152-8. PubMed ID: 376458
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.
Klotz U; Müller-Seydlitz P; Heimburg P
Clin Pharmacokinet; 1978; 3(5):407-18. PubMed ID: 699462
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics and tissue distribution of the new antiarrhythmic agent lorcainide (R 15889) in rats.
Klotz U; Golbs E
Arzneimittelforschung; 1980; 30(4):619-21. PubMed ID: 7190402
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic effect of lorcainide during chronic treatment.
Meinertz T; Kasper W; Kersting F; Bechtold H; Just H; Jähnchen E
Arzneimittelforschung; 1980; 30(9):1593-5. PubMed ID: 7193031
[TBL] [Abstract][Full Text] [Related]
5. Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction.
Leinonen H; Heikkilä J; Sundberg S; Gordin A
Ann Clin Res; 1984; 16(1):18-22. PubMed ID: 6378045
[TBL] [Abstract][Full Text] [Related]
6. Lorcainide kinetics and protein binding in patients with end-stage renal disease.
Somani P; Simon V; Gupta RK; King P; Shapiro RS; Stockard H
Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):121-5. PubMed ID: 6715079
[TBL] [Abstract][Full Text] [Related]
7. Oral flecainide acetate for the treatment of ventricular arrhythmias.
Anderson JL; Stewart JR; Perry BA; Van Hamersveld DD; Johnson TA; Conard GJ; Chang SF; Kvam DC; Pitt B
N Engl J Med; 1981 Aug; 305(9):473-7. PubMed ID: 7019711
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and the antiarrhythmic effect of mexiletine in patients with chronic ventricular arrhythmias.
Ohashi K; Ebihara A; Hashimoto T; Hosoda S; Kondo K; Oka T
Arzneimittelforschung; 1984; 34(4):503-7. PubMed ID: 6540110
[TBL] [Abstract][Full Text] [Related]
10. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
[TBL] [Abstract][Full Text] [Related]
11. Effect of enzyme induction on the disposition of lorcainide in rats following intravenous and oral administration.
Plänitz V; Jähnchen E
Arzneimittelforschung; 1984; 34(6):669-71. PubMed ID: 6541487
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of the initiation of antiarrhythmic therapy with lorcainide.
Winkle RA; Keefe DL; Rodriguez I; Kates RE
Am J Cardiol; 1984 Feb; 53(4):544-51. PubMed ID: 6198895
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
Meinertz T; Kasper W; Stengel E; Waldecker B; Löllgen H; Jähnchen E; Bechtold H; Just J
Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160
[TBL] [Abstract][Full Text] [Related]
14. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
Klempt HW; Nayebagha A; Fabry E
Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
[TBL] [Abstract][Full Text] [Related]
15. Lorcainide infusion in the treatment of ventricular premature beats (VPB).
Klotz U; Müller-Seydlitz PM; Heimburg P
Eur J Clin Pharmacol; 1979 Aug; 16(1):1-6. PubMed ID: 499295
[No Abstract] [Full Text] [Related]
16. Lorcainide disposition kinetics in arrhythmia patients.
Kates RE; Keefe DL; Winkle RA
Clin Pharmacol Ther; 1983 Jan; 33(1):28-34. PubMed ID: 6848296
[TBL] [Abstract][Full Text] [Related]
17. [Acute and long-term antiarrhythmia effect of encainide in chronic atrial extrasystole].
Thale J; Klein H; Shanks RG; Bender F
Z Kardiol; 1985 Apr; 74(4):220-7. PubMed ID: 2408392
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of lorcainide, a new antiarrhythmic drug, in patients with cardiac rhythm disorders.
Somani P
Am J Cardiol; 1981 Jul; 48(1):157-63. PubMed ID: 7246437
[TBL] [Abstract][Full Text] [Related]
19. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
Bluschke V; Breithardt G; Abendroth RR; Seipel L
Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
